FDA Inspection 1308536 — Inspira Health Network IRB
The FDA completed an inspection of Inspira Health Network IRB on Mar 11, 2026 in Vineland, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Vineland, NJ (United States)
Additional details
IRB